Ironwood Pharmaceuticals, Inc.
IRWD
$1.45
-$0.005-0.35%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 91.59M | 94.40M | 74.88M | 117.55M | 113.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 91.59M | 94.40M | 74.88M | 117.55M | 113.74M |
| Cost of Revenue | 29.83M | 30.39M | 25.82M | 39.38M | 32.79M |
| Gross Profit | 61.77M | 64.01M | 49.06M | 78.18M | 80.95M |
| SG&A Expenses | 36.11M | 36.56M | 37.61M | 46.97M | 32.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.94M | 66.95M | 63.42M | 86.34M | 65.13M |
| Operating Income | 25.65M | 27.44M | 11.46M | 31.21M | 48.61M |
| Income Before Tax | 17.37M | 18.88M | 4.96M | 30.36M | 31.93M |
| Income Tax Expenses | 13.72M | 19.74M | 9.12M | 32.11M | 17.98M |
| Earnings from Continuing Operations | 3.65M | -860.00K | -4.16M | -1.75M | 13.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 658.00K | 1.37M |
| Net Income | 3.65M | -860.00K | -4.16M | -1.09M | 15.32M |
| EBIT | 25.65M | 27.44M | 11.46M | 31.21M | 48.61M |
| EBITDA | 26.56M | 27.55M | 11.97M | 31.72M | 49.12M |
| EPS Basic | 0.02 | -0.01 | -0.03 | -0.01 | 0.10 |
| Normalized Basic EPS | 0.07 | 0.08 | 0.02 | 0.10 | 0.17 |
| EPS Diluted | 0.02 | -0.01 | -0.03 | -0.01 | 0.09 |
| Normalized Diluted EPS | 0.07 | 0.08 | 0.02 | 0.10 | 0.14 |
| Average Basic Shares Outstanding | 159.71M | 159.01M | 157.70M | 156.01M | 155.89M |
| Average Diluted Shares Outstanding | 160.23M | 159.01M | 157.70M | 156.01M | 186.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
